Skip to main content
Nature Communications logoLink to Nature Communications
. 2023 Oct 31;14:6961. doi: 10.1038/s41467-023-42266-7

The structure of a hibernating ribosome in a Lyme disease pathogen

Manjuli R Sharma 1, Swati R Manjari 1, Ekansh K Agrawal 1,4, Pooja Keshavan 1, Ravi K Koripella 1,5, Soneya Majumdar 1, Ashley L Marcinkiewicz 2, Yi-Pin Lin 2,3, Rajendra K Agrawal 1,3,, Nilesh K Banavali 1,3,
PMCID: PMC10618245  PMID: 37907464

Abstract

The spirochete bacterial pathogen Borrelia (Borreliella) burgdorferi (Bbu) affects more than 10% of the world population and causes Lyme disease in about half a million people in the US annually. Therapy for Lyme disease includes antibiotics that target the Bbu ribosome. Here we present the structure of the Bbu 70S ribosome obtained by single particle cryo-electron microscopy at 2.9 Å resolution, revealing a bound hibernation promotion factor protein and two genetically non-annotated ribosomal proteins bS22 and bL38. The ribosomal protein uL30 in Bbu has an N-terminal α-helical extension, partly resembling the mycobacterial bL37 protein, suggesting evolution of bL37 and a shorter uL30 from a longer uL30 protein. Its analogy to proteins uL30m and mL63 in mammalian mitochondrial ribosomes also suggests a plausible evolutionary pathway for expansion of protein content in mammalian mitochondrial ribosomes. Computational binding free energy predictions for antibiotics reflect subtle distinctions in antibiotic-binding sites in the Bbu ribosome. Discovery of these features in the Bbu ribosome may enable better ribosome-targeted antibiotic design for Lyme disease treatment.

Subject terms: Cryoelectron microscopy, Bacterial structural biology, Ribosome, Pathogens


Ribosomes are prime targets for antibiotics in pathogenic bacteria. Here, cryo-electron microscopy reveals features in the Borrelia burgdorferi ribosome that provide insights into ribosome evolution, dormancy, and antibiotic binding.

Introduction

Lyme disease affects up to 14.5 % of the human population worldwide1 and is the most prevalent tick-borne disease in the Northern hemisphere, including the United States2. Its causative agent is the spirochete bacteria genospecies complex, Borrelia burgdorferi sensu lato (also known as Borreliella burgdorferi sensu lato or Lyme borreliae), which includes the species Borrelia burgdorferi sensu stricto (Bbu), the primary cause of human Lyme disease in North America. Elongated seasons and widened habitats for the tick vectors driven by climate change are resulting in its continued rise3. Bbu transmitted from tick saliva into human skin after the tick bite can spread and affect the human cardiovascular and nervous systems4. The direct economic burden of Lyme disease on the United States healthcare system alone is estimated to be a multi-billion amount each year5.

The ribosome is an RNA-protein molecular machine that coordinates the vital process of protein synthesis in all living organisms6. Over two decades of detailed structural studies on various prokaryotic and eukaryotic ribosomes have clarified various aspects of the four mechanistic steps of translation – initiation, elongation, termination, and recycling79. However, even in prokaryotes, new 70S ribosome structures continue to reveal unexpected functional and compositional features, such as the discovery of structural basis of specific ribosome hibernation mechanisms1017 and presence of new smaller ribosomal proteins14,1820.

When diagnosed early in the infection, Lyme infections can be adequately treated with antibiotics, including ribosome-targeting antibiotics such as doxycycline and erythromycin21. Recently, hygromycin A (HygA), a ribosomal large (50S) subunit-binding antibiotic, was discovered to be extremely selective in resolving Bbu infections22. Knowledge of the structural details of the Bbu ribosome are therefore highly relevant for designing better biomedical interventions for Lyme disease.

In this work, we report single particle cryogenic electron microscopy (cryo-EM) structures for a hibernating Bbu 70S ribosome at 2.9 Å resolution and a 70S dissociation product form or assembly intermediate form of a Bbu 50S subunit at 3.4 Å resolution. A Bbu hibernation promoting factor protein (bbHPF) and two ribosomal proteins that are not annotated in the Bbu genome, bS22 and bL38, are found in the Bbu ribosome. A unique N-terminal α-helical extension in the Bbu ribosomal protein uL30 partially resembles the bL37 protein in mycobacterial ribosomes. The mammalian mitochondrial ribosomal proteins uL30m and mL63 are also analogous to the Bbu uL30 protein. These findings suggest evolution of bL37 and a shorter uL30 from a longer uL30 protein and a pathway for protein content expansion in mammalian mitochondrial ribosomes. Finally, the detailed Bbu 70S ribosome structure is used to obtain computational binding free energy predictions for ribosome-targeting antibiotics in clinical use for Lyme disease.

Results and discussion

Overall structure of the Bbu hibernating 70S ribosome

In this study, we report a cryo-EM structure for the 70S Bbu ribosome in its hibernating state solved at a resolution of 2.9 Å. The local resolution of the Bbu ribosome density is near the Nyquist limit of 2.2 Å in the core regions of the ribosome with the flexible regions such as parts of the small (30S) subunit head, the large (50S) subunit components such as uL1 stalk, the uL7/uL12-stalk base and uL9 showing lower resolution (Fig. 1a, Supplementary movie 1). The structure contains 58 resolved components (Supplementary Table 1, Fig. 1b): 3 ribosomal RNAs (23S, 5S, 16S), 1 tRNA in the E-site (Fig. 1c, d), 21 proteins in the small subunit - uS3 through bS22 and the bbHPF protein, and 33 proteins in the large subunit - uL1 through bL38 (Supplementary Fig. 1). Of these, the existence of two previously unknown Bbu ribosomal proteins is revealed directly through their cryo-EM density: bS22 in the small subunit (Fig. 1c, e) and bL38 in the large subunit (Fig. 1c, f). The uL30 protein in Bbu is enlarged through an N-terminal extension (Fig. 1c, g) that occupies the same site as the much smaller helical ribosomal protein bL37 in mycobacterial ribosomes. The secondary structures for the Bbu 23S RNA and 5S RNA are depicted in Supplementary Fig. 2 and the secondary structure for the 16S RNA is depicted in Supplementary Fig. 3. These secondary structure depictions are consistent with the tertiary structure of the ribosomal RNAs modeled into the Bbu 70S cryo-EM density.

Fig. 1. Bbu 70S hibernating ribosome structure and protein components.

Fig. 1

a Cryo-EM density map of 70S with local resolution indicated by color. b Model fit into cryo-EM density map with 30S density in khaki, 50S density in blue, 16S RNA and 5S RNA in orange, 23S RNA in red, 30S proteins in green, and 50S proteins in blue. c Notable components in the structure shown within the cryo-EM density map. These components of the hibernating 70S ribosome, shown in ribbon format with known sidechains in stick format, are d the E-site tRNA (orange), e the bS22 protein (cyan), f the bL38 protein (green), g the longer uL30 protein (dark green), and h the bbHPF protein (blue).

The bbHPF protein and its ribosome interactions

The single 97 amino-acid (aa) residue hibernation promoting factor gene in Bbu, named bb0449 in the KEGG database23 (Uniprot ID: A0A8F9U6W1), was previously reported to have low mRNA transcript and expressed protein levels during various growth phases-24. The expressed protein did not localize to the ribosome-associated protein fraction, and its gene deletion did not affect the mouse-tick infectious cycle24. Based on these observations, it was suggested that the 97 aa-residue bbHPF may not play its conventional role in ribosome hibernation24. There are two known mechanisms for formation of a hibernating ribosome by dimerization in bacteria: (a) The ribosome modulation factor (RMF) protein, e.g., in Escherichia coli (Eco), first helps form a 90S ribosome dimer that then gets converted to a 100S dimer by binding of the shorter form of HPF protein16, (b) a longer form of HPF protein with a C-terminal dimerization domain, e.g., in Staphylococcus aureus (Sau), directly mediates the formation of a 100S dimer by forming a dimer itself with a second HPF C-terminal domain10. The Bbu genome has no annotated RMF or longer HPF protein, so a 70S hibernating ribosome is more probable than a 100S hibernating ribosome dimer.

The bbHPF protein is a shorter HPF resembling the E. coli YfiA and HPF proteins and differs from “long” HPFs in lacking a C-terminal dimerization domain, which forms a dimerization interface that stabilizes a hibernating 100S ribosome dimer in certain bacteria10,12,15,17. In our structure, we find bbHPF bound to the decoding center in the small subunit of the Bbu 70S monosome, thereby confirming the sequence-based expectation that it does play a role in 70S ribosome hibernation (Fig. 1c, h). Its binding site overlaps with the expected binding site for doxycycline suggesting that simultaneous binding of the two may not occur. An E-site tRNA was found interacting with the C-terminal end of bbHPF with no mRNA density near it. Maintenance of the bbHPF and E-site tRNA densities in all sub-classes of the 70S ribosome obtained through multiple 3D classifications suggest that bbHPF and E-site tRNA colocalize on the hibernating Bbu 70S ribosome and are not a combined density due to two separate bbHPF bound or E-site tRNA-bound Bbu 70S ribosome populations.

Including the bbHPF structure reported in this work, atomic resolution structures for eight HPF proteins from seven different bacterial species are now known (Supplementary Table 2). When aligned by primary protein sequence, multiple positions in these HPF proteins have similar amino acids, but Leu83 is the only fully conserved amino-acid residue (Table 1 and Supplementary Table 3). This suggests that a certain level of sequence divergence is tolerated in the HPF domain that binds at the decoding center of bacterial ribosomes during their hibernation. This HPF domain is structurally similar in all these bacterial species, having a fold with two α-helices and four β-strands in a β1-α1-β2-β3-β4-α2 topology, with β1 and β2 strands forming a parallel β-sheet and the β2, β3, and β4 strands forming an antiparallel β-sheet continuous with the first parallel β-sheet. There seems to be permissibility for an increase in the size of some of the β strands or α helices (e.g., β1 or α1), a break in the helicity of an α-helix (α1), and increases in the sizes of the loops between β-strands (β2-β3 or β3-β4) (Table 1). The YfiA protein (Uniprot ID: P0AD49) and the HPF protein (Uniprot ID: P0AFX0) in Eco differ in sequence but both bind the same decoding center site in the Eco ribosome, indicating intra-species sequence permissibility in HPF-ribosome interaction. There are multiple structures of the Eco YfiA bound to the Thermus thermophilus (Tth) ribosome16,2531, indicating that inter-species permissibility also exists in HPF-ribosome interaction. There is also internal structural variability in the HPFs, as seen in the overlay of these known HPF structures aligned to each other (Fig. 2b), and additional positional variability of the HPFs in their binding pocket, as seen in the overlay of these known HPF structures bound to a bacterial ribosome with the structures aligned using the 16S ribosomal RNA (Fig. 2c). Taken together, this evidence suggests that occupation of the bacterial small subunit decoding center binding site does not require a highly conserved HPF sequence, a very rigid HPF structure, or a very restrictive positioning of the HPF in its ribosomal binding site.

Table 1.

Curated sequence alignment for bacterial HPFs with known structures

graphic file with name 41467_2023_42266_Tab1_HTML.jpg

Sequences initially aligned using Clustal2.1. Bbu - Borreliella burgdorferi (O51405), Sau - Staphylococcus aureus (D2Z097), Tth - Thermus thermophilus (Q5SIS0), Eco1Escherichia coli YfiA (P0AD49), Eco2Escherichia coli HPF (P0AFX0), CbuCoxiella burnetii (Q83DI6), VchVibrio cholerae (H9L4N9), MsmMycobacterium smegmatis (A0QTK6), AbaAcinetabacter baumannii (V5V8V8). Uniprot IDs for proteins in parentheses after species name. BbHPF numbered secondary structure elements shown on top as α-helix (a) or β-strand (b). Bacterial HPF sequences are truncated to within four residues of bbHPF sequence.

Fig. 2. The bbHPF binding site orientation and bacterial HPF protein structural variability.

Fig. 2

(a) Subunit interface (left), mRNA exit (middle), and mRNA entry (right) site views of bbHPF in its decoding center binding site in the Bbu ribosome with full 30S view shown above. Labels indicate location of ribosomal proteins (in blue) uS7, uS9, uS12, E-site tRNA (in yellowish orange, labeled E-tRNA), and large subunit RNA helix 69 (in dark orange, labeled H69) of the 23S ribosomal RNA. 16S ribosomal RNA shown in semitransparent light orange. Known bacterial HPF structures, with resolutions better than 3.5 Å, shown in transparent khaki, b aligned by HPF protein residues, showing internal structural variability, and c aligned by 16S ribosomal RNA residues, showing position variability in their ribosomal binding site. BbHPF is shown as opaque red in all panels. Views shown in panels b, c are analogous to those shown in panel (a). Details of structures used in panels b, c are listed in Supplementary Table 2.

Including the structure reported in this work, there are four ribosome structures with HPF proteins and E-site tRNA both modeled into the density map. These include a hibernating Mycobacterium smegmatis (Msm) ribosome structure (PDB ID: 5ZEP32) and two Eco hibernating ribosome structures (PDB IDs: 6H4N11, 6Y6933). When aligned using the HPF protein, there is a clear relative motion revealed between the HPF protein and the E-tRNA in the four structures (Supplementary movie 2). The Msm structure and the Eco structures show substantially different relative HPF and E-tRNA orientations and the Bbu structure shows an intermediate relative orientation (Supplementary Fig. 4). When aligned using the small subunit 16S RNA, both the HPF protein and the E-tRNA adjust their relative positions with respect to the ribosome such that overall binding of the two appears roughly similar in all four structures (Supplementary Fig. 5). HPF and the anti-codon stem loop of E-tRNA interact, which likely helps inhibit ribosome activity11. The larger difference between the HPF and E-tRNA relative orientations for Msm and Eco/Bbu may originate from the Msm HPF being a longer HPF with a C-terminal domain and its neighboring E-tRNA adjusting to the presence of its linker to its C-terminal domain. There is no mRNA density modeled near the E-tRNA in any of these structures, suggesting that the C-terminal end of the HPF protein and the 30S environment in that region help stabilize the anti-codon stem loop part of the E-tRNA in hibernating ribosomes.

Small ribosomal subunit

The Bbu small subunit unexpectedly showed a clear density for a helical protein in the binding pocket seen to be occupied by the bS22 protein in mycobacterial14,18,19 and Bacteroidetes20 ribosome structures. There was no annotated bS22 protein in the Bbu genome necessitating identification of the protein sequence through a translated nucleotide genome search. Borrelia species can be phylogenetically grouped into three lineages, Lyme borreliae, relapsing fever borreliae, and reptile- and echidna-associated Borrelia34. Using an approach described in the Supplementary note 1, the bS22 protein sequence (bb0822) was identified as using a non-canonical GUG start codon and confirmed in two ways: (a) modeling of the protein sequence into the cryo-EM density map and finding good sidechain density fits (Fig. 1e), (b) finding the same conserved sequence protein in all three groups of Borrelia species (Supplementary Table 4). bb0822 spans the nucleotide range 867605-867697 in the Bbu chromosome (Genbank ID: AE000783.1). A transposon library in Bbu showed transposon insertions in only 35% of genes in the linear chromosome with the bb0822 gene encoding bS22 grouped among the 601 essential gene candidates with no insertions35. The bS22 transcript is also highly abundant in fed nymphs and its production was not significantly different between infected hosts and tick vectors36.

The Bbu bS22 protein has greater structural and sequence homology with the Flavobacterium johnsoniae (Fjo) bS22 protein than the Msm bS22 protein (Fig. 3, Supplementary Note 1). It is highly basic, with 61% of its residues being either lysine or arginine. This presumably aids its binding to an RNA pocket formed by the 16S RNA helices h2, h27, h44, h45, and its interaction with the 23S RNA helix H68 (Fig. 3) upon association with the 50S ribosomal subunit. Amongst the three groups of Borrelia species, only one residue change is observed in this protein sequence (K10Q), which occurs in Borrelia miyamotoi, Borrelia hermsii, Borrelia parkeri, Borrelia venezuelensis, and Borrelia turicatae, while all other amino acids are completely conserved (Supplementary Table 4). This protein is likely to be discovered in other bacterial species since its shorter length and non-canonical start codon possibility may pose difficulty for automated protein annotation tools and the ribosomal RNA pocket to which it binds is structurally conserved. Just like Msm and Fjo bS22 proteins, the Bbu bS22 protein is analogous to the eukaryotic mitochondrial small subunit protein mS383739 and the eukaryotic cytosolic protein eL4140 (Fig. 3e–h). The mS38 protein, also called the Aurora kinase A interacting protein, is a longer protein with a bent helical structure in which the bend is at the same location as in the Bbu, Fjo, and Msm bS22 proteins (Fig. 3g). The eL41 protein, although named as a large ribosomal subunit protein, is localized within the small subunit-binding pocket in eukaryotic ribosomes40, except for the thermophilic fungus Chaetomium thermophilum (Cth), where it is also found in a large subunit pocket41. It has only one helix with 24 aa residues, is shorter than the Bbu bS22 protein, and has no bend in its structure (Fig. 3f). These similarities among bS22 and its eukaryotic analogs suggest that these ribosomal proteins qualify for a universal name, instead of them being named separately as distinct bacterial, mitochondrial, or eukaryotic ribosomal proteins.

Fig. 3. The bS22 protein structure in Bbu and other organisms.

Fig. 3

a Bbu bS22 (blue) in the Bbu ribosome binding pocket; b Msm bS22 (cyan) in the Msm ribosome binding pocket; c Fjo bS22 (green) in the Fjo ribosome binding pocket; d Overlay of all three bS22 proteins and their respective binding pockets showing the high structural similarity in the three binding pockets with 16S RNA shown in orange and 23S RNA shown in red; e Bbu bS22 protein; f Homo sapiens (Hsa) eL41 protein; g Hsa mitochondrial mS38 protein; h overlay of Bbu bS22, Hsa eL41, Hsa mS38 proteins; i Molecular interactions of Bbu bS22 protein with the ribosomal RNA components of the binding pocket, interacting 16S RNA helix numbers in orange, interacting 23S RNA helix numbers in red.

The Bbu ribosome resembles the Fjo ribosome more than the Msm ribosome in another aspect – the presence of the bS21 protein. The bS21 protein in the Fjo ribosome, along with the proteins bS6 and bS18, are proposed to help form a binding site for sequestering the Anti-Shine-Dalgarno (ASD) sequence for efficient translation of mRNA transcripts that do not contain a Shine-Dalgarno (SD) sequence20. This binding pocket is also present in the Bbu ribosome but has some differences (Supplementary Note 2). The bS21 protein’s C-terminal end in Bbu is longer than that in Fjo and forms a well-ordered longer helix (Supplementary Fig. 6). The bS6 C-terminal end is also longer in Bbu but like the ASD sequence region of Bbu 16S RNA is not resolved in the cryo-EM density map. However, the bS6 C-terminal end does show a propensity to form a short helix like the Fjo bS6 in the predicted Alphafold model of full-length bS6 (Supplementary Fig. 4d). Only some of the specific residues implicated in stabilizing the ASD sequestration in Fjo20 are maintained in Bbu (Fjo bS18 Gln58, Phe50, Leu62, Leu66 are analogous to Bbu bS18 Gln59, Phe51, Leu63 and Ile67). Other such residues are altered, e.g., Tyr54 in Fjo bS21 is replaced by Lys53 in Bbu bS21. Even with these differences, it is possible that this binding pocket in the Bbu ribosome can stabilize the ASD sequence in Bbu 16S RNA, perhaps to a lesser extent than Fjo, which might especially be useful when translating leaderless mRNA transcripts that occur with a high frequency in Bbu.

Large ribosomal subunit

In the Bbu ribosome large subunit, there is a structural feature that has not been previously observed in any bacterial ribosome structure. The uL30 protein in Bbu (Fig. 1c, g) is a structural and functional representation of two separate ribosomal proteins – uL30 and bL37 (Fig. 4a, b, Supplementary movie 3). The bL37 protein, a small helical protein that has only been found in mycobacterial ribosomes so far, occupies a pocket near the peptidyl transferase center (PTC). In Bbu, there is no separate bL37 protein, but a N-terminal helical extension of uL30 occupies the same pocket by adopting a bent helical structure (Fig. 4a, c). A sequence comparison of the mycobacterial bL37 protein and the Bbu uL30 N-terminal extension is shown in Supplementary Note 3. Helical N-terminal extensions of uL30 are present in non-Borrelia bacterial species (Supplementary Fig. 7) as well as in other Borrelia species (Supplementary Fig. 8), indicating that this feature is not unique to Bbu. The binding pocket accommodating the N-terminal Bbu uL30 extension is composed of nucleotide residues from the 23S rRNA helices H39-H42 and H89, as well as 5S RNA nucleotide residues (Fig. 4d). The Bbu uL30 protein can also likely be expressed in a shorter form not containing the N-terminal helix before the bend (i. e., the helix corresponding to mycobacterial bL37), which suggests that the occupation of the bL37 pocket could be controlled by regulating the relative expression of these shorter and longer forms of Bbu uL30 (Supplementary Fig. 8). The Bbu uL30 protein resembles the mammalian cytosolic uL30 protein in having an N-terminal helical extension, except that the uL30 N-terminal helical extension in the mammalian cytosolic ribosome is not bent and is oriented in a different direction (Fig. 4f). The Bbu uL30 protein also has similarities to mammalian mitochondrial proteins uL30m and mL63, which together occupy the analogous regions in the mammalian mitochondrial ribosomal large subunit (Fig. 4gi). These observations suggest the possibility that an N-terminal extension of uL30 might have evolutionarily bifurcated into two proteins in mycobacteria and mammalian mitochondria. Ribosomal protein expansions have coevolved in mammalian mitochondrial ribosomes in conjunction with ribosomal RNA reductions3739,4245. Bifurcation and subsequent expansion of one or both resulting ribosomal proteins may provide a mechanism by which this evolution occurred.

Fig. 4. The structure of the longer uL30 protein in Borreliella species and its relationship with the bL37 protein in mycobacteria, the Hsa uL30 protein, and the Hsa mL30 and mL63 proteins.

Fig. 4

a The Bbu uL30 protein (blue) in its structurally conserved 23S RNA (light orange) and 5S RNA (purple) environment, with the extracted uL30 and 5S RNA shown below for clarity. b The Msm uL30 protein (green) and the Msm bL37 protein (yellow) in its structurally conserved 23S RNA (light orange) and 5S RNA (red) environment, with the extracted uL30, bL37, and 5S RNA shown below. c Overlays of the Bbu uL30 protein and the Msm uL30 and bL37 proteins (left), and the neighboring Bbu (purple) and Msm (red) 5S RNA segments (right). d The ribosomal RNA binding pocket for the uL30 N-terminal extension (residue 2-40), blue asterisk indicates 5S RNA. e The Bbu uL30 protein. f The Hsa uL30 protein. g The Hsa uL30m protein. h Overlay of the Bbu uL30 protein (blue) and the Hsa mL63 protein (yellow). i Overlay of the Bbu uL30 protein and the Hsa uL30m and Hsa mL63 proteins.

The Bbu ribosomal large subunit also has a clear density corresponding to the recently identified bL38 protein in the Fjo ribosome structure (Fig. 1c, f). A ribosomal protein at this location was not expected to be found in Bbu as there is no annotated bL38 protein in the Bbu genome. We were not able to identify a protein sequence corresponding to this density in the Bbu genome through a translated nucleotide search using the Fjo bL38 sequence. The density was strong enough to create a reliable backbone model and had some clear sidechain densities that would help distinguish between candidate sequences but our attempts to use de novo methods to identify a sequence for this protein through the cryo-EM density alone were not successful. We first built a well-fitting C-α atom model of a protein based on the cryo-EM density map. We then performed long-gradient Liquid Chromatography Tandem Mass spectrometry (LC–MS/MS) analysis of the proteins in the purified ribosomes. As described in Supplementary Note 4, we were able to use these to unambiguously assign the Bbu bL38 protein as the previously unidentified gene bb0162 (Uniprot ID: O51184).

Although placed in a similar location in the 50S subunit and its binding region being structurally conserved (Fig. 5a–c), the Bbu bL38 protein shows some characteristics distinct from the bL38 protein in Fjo. The Bbu bL38 protein interacts with the 23S RNA helix 95 (H95) containing the α-sarcin-ricin loop (SRL) and may influence the binding of multiple GTPases that interact with the SRL to perform their function (Supplementary Fig. 9). It has 9 residues at its N-terminal end that are not well-resolved in the cryo-EM density. Since Bbu bL38 is displaced by 14 Å towards the uL14 and bL19 proteins as compared to the Fjo bL38 protein (Fig. 5d), its unresolved N-terminal residues might be interacting dynamically with these proteins. The Bbu bL38 protein also shows an internally distinct structure as compared to Fjo bL38 (Fig. 5e), in having a small third β-strand followed by a short α-helix that contain additional positively charged residues participating in a 5-residue (K34, K36, R49, K50, and R52) spine of interaction with the 23S RNA (Fig. 5f). Additional backbone interactions with uL6 and sidechain interactions with residues T111 and E114 from uL6, backbone interactions with uL14, and interactions with multiple residues from the 23S RNA helices H95 and H97 stabilize bL38 binding to the 50S subunit.

Fig. 5. Ribosome interactions of the Bbu bL38 protein.

Fig. 5

a 50S subunit neighborhood of Bbu bL38 (green), b 50S subunit neighborhood of Fjo bL38 (yellow), c Overlay using 23S RNA of (a) and (b) showing displacement of Bbu bL38 as compared to Fjo bL38 while the neighborhood remains structurally conserved, d relative displacement of Bbu bL38 as compared to Fjo bL38 in overlay, e Internal structural differences between Bbu bL38 and Fjo bL38 when overlaid on each other, f detailed atomic interactions of Bbu bL38 with Bbu 50S subunit shown from two opposite views. The coloring is as follows: uL6 in cyan, uL14 in pink, bL19 in orange, Bbu bL38 in dark green, Fjo bL38 in yellow, 23S RNA in red. The Fjo models are shown in transparent view to facilitate comparison with Bbu in the overlay.

23S RNA Helix 68 disorder in the large ribosomal subunit

Three-dimensional (3D) classification of the cryo-EM particle images was done to find out if: (a) the subunit ratcheting motion46 was occurring in the hibernating ribosome; (b) there was a proportion of non-hibernating ribosomes; (c) the HPF protein and the E-tRNA were colocalizing on the 70S ribosome or were a combined density consisting of two different populations; and (d) there were additional protein densities in sub-populations of the particle images obtained. The 3D classification did not yield clearly different structural populations, which suggests that our sample of the hibernating Bbu 70S ribosome was mostly homogeneous (Supplementary Fig. 10). Some variability was observed in the presence or absence of parts of the bS2 protein density, but no individual class could be identified with a complete bS2 density present. A small number of particles could be separated into a class mostly corresponding to the 50S subunit with a miniscule proportion of 70S particles within it that could not be eliminated entirely. This class of 12,449 particles was used to reconstruct a Bbu 50S subunit structure at a resolution of 3.4 Å (Supplementary Fig. 11a). The protein densities corresponding to the full-length uL30 and bL38 proteins were found unaltered in the 50S subunit structure (Supplementary Fig. 11b–e), confirming that both these proteins are stable components of the 50S subunit.

A surprising finding in this 50S subunit structure was that the long and usually well-resolved 23S RNA helix H68 was not even partially ordered (Supplementary Fig. 12). This disorder, also present for the usually flexible H69, seems to be greater than the alternate conformations identified for H68 in the Sau 50S subunit and 70S ribosome at physiological temperature (Supplementary Fig. 13, Supplementary movie 4) that were suggested to be involved in the ribosomal translocation mechanism47. A lowering of the density threshold values shows some ordering of H68 but only with simultaneous appearance of the fragmented 30S subunit densities, suggesting that this ordering may be attributable to the small number of 70S particles in this class, which could not be computationally removed. One explanation for the H68 disorder is that the 70S sucrose gradient fraction has some not-fully-assembled 50S population. Known 50S assembly intermediates48,49 are listed in Supplementary Table 5 and compared to the Bbu 50S map in Supplementary Fig. 14. Since no proteins are missing in the Bbu 50S structure and the only unusually disordered 23S RNA region is helix H68, it could be a late 50S assembly intermediate structure.

Another explanation is that this 50S population is formed through splitting of a small 70S sub-population. Conformational variability of helices H67-H71 of the 23S rRNA recently observed in cryo-EM structures of log-phase Msm ribosomes was proposed to prevent association of the 50S subunit with the 30S subunit50. H68 having a larger conformational variability in Bbu would also be incompatible with proper 70S structure maintenance. The nearby inter-subunit bridge B7a near the L1 stalk region may be one of the final ones to dissociate during ribosomal subunit splitting51 and larger-scale H68 motions could affect this bridge. With such larger motions, the H68 helix could therefore play a role in completing the dissociation of the two Bbu ribosomal subunits. If so, the lack of any special features in H68 in Bbu as compared to other bacterial species suggests that this postulated ribosome splitting assistive role for H68 might be common to other ribosomes as well.

Antibiotic-binding pockets

This Bbu 70S ribosome structure captures details of antibiotic-binding pockets that allow construction of detailed models of antibiotics bound to it. We have modeled the structure of three antibiotics, two that are in clinical use already (doxycycline and erythromycin), and one that has recently been shown to be of great promise in treating Lyme infections (hygromycin A22) using de novo docking (Supplementary Fig. 15) and structural analogy to previous antibiotic-bound ribosome structures (Supplementary Table 6, Supplementary Fig. 16). The de novo docking, done in the vicinity of the expected binding sites, found binding poses analogous to the previous experimental structures with the Autodock Vina52 estimated binding free energies of −5.4 kcal/mol for doxycycline, −6.2 kcal/mol for erythromycin, and −7.3 kcal/mol for hygromycin A. A comparison between the hygromycin A binding site for Bbu and the same site in the Tth ribosome, with53 and without25 hygromycin A bound, reveals that some 23S RNA residues in Bbu are intrinsically positioned in conformations forming a more open binding pocket conducive to hygromycin A binding (Supplementary Fig. 17). Recent studies have shown that antibiotics may perform their function by introducing protein synthesis malfunctions in a context-specific manner54,55. In their empty ribosome binding modes, these antibiotics sterically overlap with components that bind to the translating ribosomes suggesting that they may adjust their ribosome binding modes to the presence of these other components. Structurally characterizing Bbu translation factors and Bbu tRNAs bound to its ribosome in various steps of protein translation, in the presence and absence of antibiotics, can help clarify their context-specific mechanism of action.

In summary, this study identifies unanticipated alterations in the Bbu ribosome, such as the presence of bS22, bL38, and an N-terminal extended uL30 also assuming the role of the bL37 protein. The extended uL30 being present in ancient bacterial species (Supplementary Fig. 7) as well as having eukaryotic cytosolic and mitochondrial ribosome analogies (Fig. 4e–i) suggests this to be analogous to an earlier version of uL30 in evolution that has subsequently shortened or split or expanded, which suggests an underlying mechanism for the increase in ribosomal protein numbers and masses in eukaryotic mitochondrial and cytosolic ribosomes. Our hibernating Bbu 70S ribosome structure thus provides the groundwork for better understanding ribosome dormancy, ribosome evolution, antibiotic mechanisms of action, and for development of new structure-based antibiotic therapeutics for Lyme disease.

Methods

Ribosome purification

The Bbu strain B31-A356 was inoculated in 2L BSK II complete medium and grown to the late logarithmic phase as we were interested in hibernating ribosomes, which have the additional advantage of being available in relatively large numbers in a smaller volume of cell culture. Cells were harvested and lysed by French press for two pressings at 16,000 PSI and the lysate centrifuged twice at 11,952 × g for 30 min. Formation of a pellet of spirochete cells, expected to occur after spinning at 7649 × g, was observed after the first spin. The second spin yielded a much smaller pellet. The supernatant after the second spin was examined by dark microscopy at 400X magnification for intact spirochetes. After observing cell debris from approximately three dead spirochetes in the lysate, a final spin of 34,541 × g for 45 min was done, which ensured pelleting of all the spirochete cell debris. The rest of the ribosome purification protocol57 is as follows. The supernatant was collected in a Beckman PC ultracentrifuge tube and centrifuged for 2 h and 15 min at 188,043 × g in a Beckman rotor Type 70Ti. Pellets were soaked in 2 mL of HMA-10 buffer (20 mM HEPES K pH 7.5, 600 mM NH4Cl, 10 mM MgCl2, 5 mM β-mercaptoethanol) and kept in an ice bath overnight. 16 mL of HMA-10 buffer was added and the preparation was put on a shaking rocker for one hour at 4 °C with 3 units/mL Rnase-free Dnase (Ambion) added. The contents were transferred to Beckman PA tubes and centrifuged at 21,986 × g at 4 °C for 15 min in Beckman rotor JA 30.5Ti. The supernatant was collected in Beckman ultracentrifuge PC tubes and centrifuged for 2 h and 15 min at 4 °C at 185,416 × g in a Beckman rotor Type 70Ti. Pellets were resuspended in 200 µL HMA-10 buffer and kept in an ice bath in a cold room at 4 °C overnight. The sample was then centrifuged for 6 min at 17,348 × g. The supernatant containing the ribosomes was collected and quantified by measuring optical density at 260 nm. This crude ribosome preparation was then layered on top of sucrose density gradients (10%–40%), prepared in 11 mL tubes containing HMA-10 buffer for 17 h at 55,408 × g in a Beckman rotor SW 41Ti. Ribosome fractions containing primarily 70S monosomes were collected after fractionating the sucrose gradient in a 260 nm Teledyne ISCO gradient analyzer. These pooled 70S fractions were pelleted by ultracentrifugation at 188,043 × g for 6 h in a Beckman rotor Type 70Ti, suspended in HMA-10 buffer, and quantified by measuring absorbance at 260 nm.

Protein mass spectrometry

The proteins in two 11 µL aliquots of a 350 nM Bbu ribosome preparation were reduced and alkylated to remove disulfide linkages, digested using trypsin, desalted, and then examined by long-gradient Liquid Chromatography tandem mass spectrometry (LC–MS/MS), using a Thermo Scientific LTQ-Orbitrap XL mass spectrometer. The protein sequences were identified by comparison with a Bbu reference proteome (1290 sequences) downloaded from Uniprot in 2019 (https://www.uniprot.org/proteomes?query=BORBU). The results of this analysis, performed using the Scaffold5 software, are shown in Supplementary Table 7. The bL38 protein that was not identifiable using other means, such as de novo sequence prediction from the cryo-EM density or a translated nucleotide search using the Fjo bL38 sequence, was identified successfully by this analysis. In addition, the bbHPF protein and all other ribosomal proteins except bS22 were also identified at 100% protein identification probability.

Grid preparation and imaging for cryo-EM

A home-made thin carbon film was coated as a continuous layer (about 50 Å thick) onto Quantifoil 300-mesh 1.2/1.3 grids. These grids were then glow-discharged for 30 s on a plasma sterilizer to hydrophilize the carbon film. The purified ribosome sample (4 µL) was transferred onto each grid after mounting it on a Thermofisher Vitrobot Mark IV system and the grid was maintained for 15 s at 4 °C and 100% humidity. Each grid was then blotted for 5 s with a force offset of +2 and then plunged into liquid ethane. Movies were collected in counting mode using Leginon software58 on a Thermofisher Titan Krios G3 electron microscope operating at 300 kV with a Gatan BioQuantum imaging energy filter and a Gatan K2 direct electron detection (DED) camera. The cryo-EM data collection details are shown in Table 2. A total of 4661 movies, each having 50 frames, each frame collected every 0.2 s, were obtained at a physical pixel size of 1.0961 Å. Manual curation of the movies using parameters such as estimated ice thickness and contrast transfer function (CTF) fit criteria yielded 2331 movies that were used for further cryo-EM image processing. An electron dose rate of about 8.1 electrons/pixel/second and an exposure time of 10 s yielded a total dose of 67.5 electrons/Å2.

Table 2.

Cryo-EM data collection and model refinement details

Parameters 70S ribosome 50S ribosomal subunit
Cryo-EM
Electron microscope Titan Krios G3 Titan Krios G3
Voltage (kV) 300 300
Pixel size (Å) 1.0961 1.0961
Defocus range (µM) 0.8–2.5 0.8–2.5
Electron dose/image 67.5 67.5
Particles 288,776 12,449
Software cryoSPARC v2.15 cryoSPARC v2.15
Symmetry C1 C1
FSC threshold 0.143 0.143
Average B-factor (Å2) 57.2 96.6
Resolution (Å) 2.9 3.4
Atomic model
R.M.S. deviations
 Bond lengths (Å) 0.000 0.000
 Bond angles (°) 0.089 0.103
Resolved protein residues 6239 3569
Protein rotamer outliers 22 (0.4%) 13 (0.4%)
Ramachandran favored 5831 (93.5 %) 3280 (93.0 %)
Ramachandran outliers 1 (0.016%) 1 (0.028%)
Resolved RNA residues 4646 2867
RNA sugar pucker outliers 64 (1.4%) 33 (1.2%)
RNA suite outliers 790 (17.0%) 428 (14.9%)
RNA Suiteness 0.61 0.64
Clash score 7.5 7.1

Data processing for cryo-EM

Movies were processed using patch motion and patch contrast transfer function (CTF) correction implemented in cryoSPARC v2.1559. The micrographs were curated to remove those with CTF fits worse than 5 Å and those with relative ice thickness greater than 1.05. Template-based auto-picking of particles was done using the template picker module in cryoSPARC with the input 2D templates (100 equally spaced views) obtained from an earlier 3.9 Å resolution reconstruction volume of the hibernating Bbu ribosome generated from data collected on the local JEOL3200FSC 300 KV electron microscope using our automation protocol for SerialEM60. The automated particle picks were filtered for particles with normalized correlation coefficient (NCC) > 0.2 and a signal amplitude between 3175 and 5454, which selected a total of 541,319 particles and excluded 98,553 particles. The selected particles were extracted from the corrected micrographs at a box size of 380 pixels and then further filtered using multiple iterations of 2D classifications, each followed by selection of good particle classes prior to using them as input for the next 2D classification, yielding a final selection of 288,776 particles used for further processing. These particles were used for generating a 3D reconstruction using ab initio reconstruction, homogeneous refinement, non-uniform refinement61, and finally local non-uniform refinement with the mask from the previous refinement, whose final gold-standard 3D refinement resolution was 2.9 Å. Further classification was attempted using 3D variability analysis, heterogeneous refinement, and ab initio reconstruction with multiple classes, but the resulting classes showed only small differences from each other, such as presence or absence of fragmented partial density of uS2 protein, suggesting that the particles mostly represented a homogeneous population. The only exception was a small class of 12,449 particles consisting of mostly 50S subunit particles with a slight contamination of 70S particles, whose final gold-standard resolution was 3.4 Å.

Model building and refinement

The initial models for the 23S, 16S, and 5S ribosomal RNAs were built by manually aligning the Bbu sequences to the corresponding sequences of the mycobacterial18 ribosomal RNAs and using RNA homology modeling program Moderna62 to generate initial homology models using a known RNA structure (PDB ID: 5O61)18. The RNA secondary structures for the Bbu 23S, 16S, and 5S ribosomal RNAs were obtained from their modeled 3D structures using the RNA PDBEE server63,64 and, with the aid of the R2DT server65, were manually converted to the image format provided in the supplementary material. Initial atomic models for all Bbu ribosomal proteins and bbHPF were built using Alphafold266. Manual rebuilding of incorrectly modeled regions was performed using UCSF Chimera v1.1667 followed by restrained local real-space refinement in Phenix v1.1868.

The UCSF ChimeraX69,70 matchmaker module was used for structural overlays of proteins (command line: mm #1 to #0) or RNA (command line: mm #1 to #0 matrix Nucleic). The predicted Local Distance Difference Test (pLDDT) score statistics for starting Alphafold models for proteins included in the reported structures are shown in Supplementary Table 8. The details of RNA structure overlays for antibiotic-bound structures are shown in Supplementary Table 9 and for HPF-bound structures are shown in Supplementary Table 10. The antibiotic docking was performed using Quickvina71 with the Autodock Vina scoring function52. The structures for the antibiotics and ribosome were prepared using the Autodock72 prepare_ligand4.py and prepare_receptor4.py programs. Initial structures for the antibiotics came from their highest resolution ribosome-bound conformation. The hygromycin sugar ring conformations, which started from their experimentally known conformation, were not expected to vary during docking. The docking was performed with a box centered around the expected antibiotic-binding site, with the exhaustiveness parameter set to 32 and number of modes set to 100. These parameters yielded correct docked poses for hygromycin A in its binding site in the Thermus thermophilus (Tth) ribosome (PDB ID: 5DOY53) with a predicted binding free energy of −9.0 kcal/mol, tetracycline in its binding site in the Eco ribosome (PDB ID: 5J5B73) with a predicted binding free energy of −5.7 kcal/mol, and erythromycin in its binding site in the Sau ribosome (PDB ID: 6S0Z74) with a predicted binding free energy of −5.9 kcal/mol. UCSF Chimera v1.1667 or UCSF ChimeraX version 1.469,70 were used to make the molecular figures, Inkscape was used to edit the RNA secondary structure depictions, and Gimp v2.10 was used to make composite figures.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Supplementary information

Peer Review File (704.2KB, pdf)
41467_2023_42266_MOESM3_ESM.pdf (38.7KB, pdf)

Description of Additional Supplementary Files

Supplementary Movie 1 (65.2MB, mp4)
Supplementary Movie 2 (3.5MB, mp4)
Supplementary Movie 3 (10.9MB, mp4)
Supplementary Movie 4 (14.7MB, mp4)
Reporting Summary (1.8MB, pdf)

Source data

Source Data (24.2MB, xlsx)

Acknowledgements

We acknowledge the use of the Wadsworth Center cryo-EM facility and the help and training provided by Chyongere Hsieh and Michael Marko for this use. We thank Joseph Wade for discussions that helped identify the bS22 protein sequence. We thank Caleb Mallery, whose graduate rotation project of antibiotic design in ribosome structures informed the antibiotic docking and structural analysis reported in this study. The cryo-EM data was collected at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center, supported by grants from the Simons Foundation (349247), NYSTAR, and the NIH National Institute of General Medical Sciences (GM103310). The mass spectrometric analysis was performed by the MS & Proteomics Resource at Yale University, which is funded in part by the Yale School of Medicine and by the Office of The Director, National Institutes of Health (S10OD02365101A1, S10OD019967, and S10OD018034). This work was supported by the NIH NIGMS grant (GM061576) to R.K.A. R.K.A. also acknowledges support to his lab through NIH R01 grants AI132422, GM139277, and AI155473.

Author contributions

M.R.S., Y-P.L., R.K.A., and N.K.B. designed the project. A.L.M. grew the Bbu culture, lysed the cells, and ensured spirochete cellular disintegration using light microscopy. P.K. purified the Bbu ribosomes. S.M. and N.K.B. performed the protein mass spectrometric data analysis. R.K.K. and N.K.B. performed the initial electron microscopy at Wadsworth Center. N.K.B. processed the cryo-EM data to generate final 3D volumes. M.R.S., E.K.A., and N.K.B. built protein models. S.R.M. and N.K.B. built ribosomal RNA and tRNA models. N.K.B. generated and refined the final combined atomic model built into the 3D volumes and performed the initial structural analysis. M.R.S., S.R.M., R.K.K., S.M., R.K.A., and N.K.B. contributed to further structural analysis and all authors participated in writing or editing the manuscript.

Peer review

Peer review information

Nature Communications thanks Brian Stevenson and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Data availability

Cryo-EM volumes and atomic models have been deposited at the EMDB and PDB databanks, respectively. The PDB entries are 8FMW (Bbu 70S hibernating ribosome structure) and 8FN2 (Bbu 50S subunit structure). The EMDB entries are EMD-29298 (Bbu 70S hibernating ribosome structure) and EMD-29304 (Bbu 50S subunit structure). Source data are provided with this paper.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Rajendra K. Agrawal, Email: rajendra.agrawal@health.ny.gov

Nilesh K. Banavali, Email: nilesh.banavali@health.ny.gov

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-023-42266-7.

References

  • 1.Dong Y, et al. Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis. BMJ Glob. Health. 2022;7:e007744. doi: 10.1136/bmjgh-2021-007744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of Lyme disease diagnoses, United States, 2010–2018. Emerg. Infect. Dis. 2021;27:616. doi: 10.3201/eid2702.202731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tran T, et al. Predicting spatio-temporal population patterns of Borrelia burgdorferi, the Lyme disease pathogen. J. Appl. Ecol. 2022;59:2779–2789. doi: 10.1111/1365-2664.14274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cardenas-de la Garza JA, la Cruz-Valadez D, Ocampo-Candiani J, Welsh O. Clinical spectrum of Lyme disease. Eur. J. Clin. Microbiol. Infect. Dis. 2019;38:201–208. doi: 10.1007/s10096-018-3417-1. [DOI] [PubMed] [Google Scholar]
  • 5.Mac S, da Silva SR, Sander B. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: a scoping review. PLoS ONE. 2019;14:e0210280. doi: 10.1371/journal.pone.0210280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Watson JD. The synthesis of proteins upon ribosomes. Bull. Soc. Chim. Biol. 1964;46:1399–1425. [PubMed] [Google Scholar]
  • 7.Rodnina MV. Translation in prokaryotes. Cold Spring Harb. Perspect. Biol. 2018;10:a032664. doi: 10.1101/cshperspect.a032664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schuller AP, Green R. Roadblocks and resolutions in eukaryotic translation. Nat. Rev. Mol. Cell Biol. 2018;19:526–541. doi: 10.1038/s41580-018-0011-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ramakrishnan V. The ribosome emerges from a black box. Cell. 2014;159:979–984. doi: 10.1016/j.cell.2014.10.052. [DOI] [PubMed] [Google Scholar]
  • 10.Khusainov I, et al. Structures and dynamics of hibernating ribosomes from Staphylococcus aureus mediated by intermolecular interactions of HPF. EMBO J. 2017;36:2073–2087. doi: 10.15252/embj.201696105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Beckert B, et al. Structure of a hibernating 100S ribosome reveals an inactive conformation of the ribosomal protein S1. Nat. Microbiol. 2018;3:1115–1121. doi: 10.1038/s41564-018-0237-0. [DOI] [PubMed] [Google Scholar]
  • 12.Beckert B, et al. Structure of the Bacillus subtilis hibernating 100S ribosome reveals the basis for 70S dimerization. EMBO J. 2017;36:2061–2072. doi: 10.15252/embj.201696189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khusainov I, et al. Mechanism of ribosome shutdown by RsfS in Staphylococcus aureus revealed by integrative structural biology approach. Nat. Commun. 2020;11:1–10. doi: 10.1038/s41467-020-15517-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li Y, et al. Zinc depletion induces ribosome hibernation in mycobacteria. Proc. Natl Acad. Sci. USA. 2018;115:8191–8196. doi: 10.1073/pnas.1804555115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Matzov D, et al. The cryo-EM structure of hibernating 100S ribosome dimer from pathogenic Staphylococcus aureus. Nat. Commun. 2017;8:1–7. doi: 10.1038/s41467-017-00753-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Polikanov YS, Blaha GM, Steitz TA. How hibernation factors RMF, HPF, and YfiA turn off protein synthesis. Science. 2012;336:915–918. doi: 10.1126/science.1218538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Flygaard RK, Boegholm N, Yusupov M, Jenner LB. Cryo-EM structure of the hibernating Thermus thermophilus 100S ribosome reveals a protein-mediated dimerization mechanism. Nat. Commun. 2018;9:1–12. doi: 10.1038/s41467-018-06724-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hentschel J, et al. The complete structure of the Mycobacterium smegmatis 70S ribosome. Cell Rep. 2017;20:149–160. doi: 10.1016/j.celrep.2017.06.029. [DOI] [PubMed] [Google Scholar]
  • 19.Li Z, et al. Cryo-EM structure of Mycobacterium smegmatis ribosome reveals two unidentified ribosomal proteins close to the functional centers. Protein Cell. 2018;9:384–388. doi: 10.1007/s13238-017-0456-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jha V, et al. Structural basis of sequestration of the anti-Shine-Dalgarno sequence in the Bacteroidetes ribosome. Nucleic Acids Res. 2021;49:547–567. doi: 10.1093/nar/gkaa1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kowalski TJ, Tata S, Berth W, Mathiason MA, Agger WA. Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a lyme disease–hyperendemic area. Clin. Infect. Dis. 2010;50:512–520. doi: 10.1086/649920. [DOI] [PubMed] [Google Scholar]
  • 22.Leimer N, et al. A selective antibiotic for Lyme disease. Cell. 2021;184:5405–5418.e5416. doi: 10.1016/j.cell.2021.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases, and drugs. Nucleic Acids Res. 2017;45:D353–D361. doi: 10.1093/nar/gkw1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fazzino L, Tilly K, Dulebohn DP, Rosa PA. Long-term survival of Borrelia burgdorferi lacking the hibernation promotion factor homolog in the unfed tick vector. Infect. Immun. 2015;83:4800–4810. doi: 10.1128/IAI.00925-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Polikanov YS, Melnikov SV, Söll D, Steitz TA. Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly. Nat. Struct. Mol. Biol. 2015;22:342–344. doi: 10.1038/nsmb.2992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Syroegin EA, et al. Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol. Nat. Struct. Mol. Biol. 2022;29:152–161. doi: 10.1038/s41594-022-00720-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tereshchenkov AG, et al. Binding and action of amino acid analogs of chloramphenicol upon the bacterial ribosome. J. Mol. Biol. 2018;430:842–852. doi: 10.1016/j.jmb.2018.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Svetlov MS, et al. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Nat. Chem. Biol. 2021;17:412–420. doi: 10.1038/s41589-020-00715-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Seefeldt AC, et al. Structure of the mammalian antimicrobial peptide Bac7 (1–16) bound within the exit tunnel of a bacterial ribosome. Nucleic Acids Res. 2016;44:2429–2438. doi: 10.1093/nar/gkv1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chen C-W, et al. Binding and action of triphenylphosphonium analog of chloramphenicol upon the bacterial ribosome. Antibiotics. 2021;10:390. doi: 10.3390/antibiotics10040390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mardirossian M, et al. The dolphin proline-rich antimicrobial peptide Tur1A inhibits protein synthesis by targeting the bacterial ribosome. Cell Chem. Biol. 2018;25:530–539.e537. doi: 10.1016/j.chembiol.2018.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mishra S, Ahmed T, Tyagi A, Shi J, Bhushan S. Structures of Mycobacterium smegmatis 70S ribosomes in complex with HPF, tmRNA, and P-tRNA. Sci. Rep. 2018;8:1–12. doi: 10.1038/s41598-018-31850-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Osterman IA, et al. Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel. Nat. Chem. Biol. 2020;16:1071–1077. doi: 10.1038/s41589-020-0578-x. [DOI] [PubMed] [Google Scholar]
  • 34.Margos G, et al. The genus Borrelia reloaded. PLoS ONE. 2018;13:e0208432. doi: 10.1371/journal.pone.0208432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lin T, et al. Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS ONE. 2012;7:e47532. doi: 10.1371/journal.pone.0047532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Iyer R, et al. Stage‐specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Mol. Microbiol. 2015;95:509–538. doi: 10.1111/mmi.12882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Greber BJ, et al. The complete structure of the 55 S mammalian mitochondrial ribosome. Science. 2015;348:303–308. doi: 10.1126/science.aaa3872. [DOI] [PubMed] [Google Scholar]
  • 38.Koripella RK, et al. Structures of the human mitochondrial ribosome bound to EF-G1 reveal distinct features of mitochondrial translation elongation. Nat. Commun. 2020;11:3830. doi: 10.1038/s41467-020-17715-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Amunts A, Brown A, Toots J, Scheres SH, Ramakrishnan V. The structure of the human mitochondrial ribosome. Science. 2015;348:95–98. doi: 10.1126/science.aaa1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Natchiar SK, Myasnikov AG, Kratzat H, Hazemann I, Klaholz BP. Visualization of chemical modifications in the human 80S ribosome structure. Nature. 2017;551:472–477. doi: 10.1038/nature24482. [DOI] [PubMed] [Google Scholar]
  • 41.Kišonaitė M, Wild K, Lapouge K, Ruppert T, Sinning I. High-resolution structures of a thermophilic eukaryotic 80S ribosome reveal atomistic details of translocation. Nat. Commun. 2022;13:476. doi: 10.1038/s41467-022-27967-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sharma MR, et al. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell. 2003;115:97–108. doi: 10.1016/S0092-8674(03)00762-1. [DOI] [PubMed] [Google Scholar]
  • 43.Mears JA, et al. A structural model for the large subunit of the mammalian mitochondrial ribosome. J. Mol. Biol. 2006;358:193–212. doi: 10.1016/j.jmb.2006.01.094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Agrawal, R. K. & Majumdar, S. The Mitoribosome: Methods and Protocols 7−21 (Springer, 2023).
  • 45.Koripella RK, et al. Distinct mechanisms of the human mitoribosome recycling and antibiotic resistance. Nat. Commun. 2021;12:3607. doi: 10.1038/s41467-021-23726-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Frank J, Agrawal RK. A ratchet-like inter-subunit reorganization of the ribosome during translocation. Nature. 2000;406:318–322. doi: 10.1038/35018597. [DOI] [PubMed] [Google Scholar]
  • 47.Cimicata G, et al. Structural studies reveal the role of helix 68 in the elongation step of protein biosynthesis. mBio. 2022;13:e00306–e00322. doi: 10.1128/mbio.00306-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ni X, et al. YphC and YsxC GTPases assist the maturation of the central protuberance, GTPase associated region and functional core of the 50S ribosomal subunit. Nucleic Acids Res. 2016;44:8442–8455. doi: 10.1093/nar/gkw678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Davis JH, et al. Modular assembly of the bacterial large ribosomal subunit. Cell. 2016;167:1610–1622.e1615. doi: 10.1016/j.cell.2016.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Baid P, Sengupta J. Cryo-EM captures a unique conformational rearrangement in 23S rRNA helices of the Mycobacterium 50S subunit. Int. J. Biol. Macromol. 2023;253:126876. doi: 10.1016/j.ijbiomac.2023.126876. [DOI] [PubMed] [Google Scholar]
  • 51.Bhattacharjee, S., Frank, J. & Feng, X. Mechanism of HflX-mediated recycling of E. coli ribosome studied by time-resolved cryo-EM. Preprint at bioRxiv10.1101/2023.01.25.525430 (2023).
  • 52.Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461. doi: 10.1002/jcc.21334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Polikanov YS, et al. Distinct tRNA accommodation intermediates observed on the ribosome with the antibiotics hygromycin A and A201A. Mol. Cell. 2015;58:832–844. doi: 10.1016/j.molcel.2015.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Vázquez-Laslop N, Mankin AS. Context-specific action of ribosomal antibiotics. Annu. Rev. Microbiol. 2018;72:185–207. doi: 10.1146/annurev-micro-090817-062329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Marks J, et al. Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center. Proc. Natl Acad. Sci. USA. 2016;113:12150–12155. doi: 10.1073/pnas.1613055113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Elias AF, et al. Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect. Immun. 2002;70:2139–2150. doi: 10.1128/IAI.70.4.2139-2150.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Datta PP, Sharma MR, Qi L, Frank J, Agrawal RK. Interaction of the G′ domain of elongation factor G and the C-terminal domain of ribosomal protein L7/L12 during translocation as revealed by cryo-EM. Mol. Cell. 2005;20:723–731. doi: 10.1016/j.molcel.2005.10.028. [DOI] [PubMed] [Google Scholar]
  • 58.Suloway C, et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 2005;151:41–60. doi: 10.1016/j.jsb.2005.03.010. [DOI] [PubMed] [Google Scholar]
  • 59.Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290–296. doi: 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
  • 60.Mastronarde DN. Advanced data acquisition from electron microscopes with SerialEM. Microsc. Microanal. 2018;24:864–865. doi: 10.1017/S1431927618004816. [DOI] [Google Scholar]
  • 61.Punjani A, Zhang H, Fleet DJ. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods. 2020;17:1214–1221. doi: 10.1038/s41592-020-00990-8. [DOI] [PubMed] [Google Scholar]
  • 62.Rother M, Rother K, Puton T, Bujnicki JM. ModeRNA: a tool for comparative modeling of RNA 3D structure. Nucleic Acids Res. 2011;39:4007–4022. doi: 10.1093/nar/gkq1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Antczak M, et al. RNApdbee—a webserver to derive secondary structures from pdb files of knotted and unknotted RNAs. Nucleic Acids Res. 2014;42:W368–W372. doi: 10.1093/nar/gku330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zok T, et al. RNApdbee 2.0: multifunctional tool for RNA structure annotation. Nucleic Acids Res. 2018;46:W30–W35. doi: 10.1093/nar/gky314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Sweeney BA, et al. R2DT is a framework for predicting and visualising RNA secondary structure using templates. Nat. Commun. 2021;12:3494. doi: 10.1038/s41467-021-23555-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–589. doi: 10.1038/s41586-021-03819-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Pettersen EF, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
  • 68.Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Goddard TD, et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 2018;27:14–25. doi: 10.1002/pro.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70–82. doi: 10.1002/pro.3943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Alhossary A, Handoko SD, Mu Y, Kwoh C-K. Fast, accurate, and reliable molecular docking with QuickVina 2. Bioinformatics. 2015;31:2214–2216. doi: 10.1093/bioinformatics/btv082. [DOI] [PubMed] [Google Scholar]
  • 72.Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J. Mol. Recognit. 1996;9:1–5. doi: 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  • 73.Cocozaki AI, et al. Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors. Proc. Natl Acad. Sci. USA. 2016;113:8188–8193. doi: 10.1073/pnas.1605127113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Halfon Y, et al. Exit tunnel modulation as resistance mechanism of S. aureus erythromycin resistant mutant. Sci. Rep. 2019;9:1–8. doi: 10.1038/s41598-019-48019-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Peer Review File (704.2KB, pdf)
41467_2023_42266_MOESM3_ESM.pdf (38.7KB, pdf)

Description of Additional Supplementary Files

Supplementary Movie 1 (65.2MB, mp4)
Supplementary Movie 2 (3.5MB, mp4)
Supplementary Movie 3 (10.9MB, mp4)
Supplementary Movie 4 (14.7MB, mp4)
Reporting Summary (1.8MB, pdf)
Source Data (24.2MB, xlsx)

Data Availability Statement

Cryo-EM volumes and atomic models have been deposited at the EMDB and PDB databanks, respectively. The PDB entries are 8FMW (Bbu 70S hibernating ribosome structure) and 8FN2 (Bbu 50S subunit structure). The EMDB entries are EMD-29298 (Bbu 70S hibernating ribosome structure) and EMD-29304 (Bbu 50S subunit structure). Source data are provided with this paper.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES